π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Multivitamin/multimineral supplements (MVI) provide important nutrition sup...
Status
Completed
Location
Brooklyn College of City University of New York
Start Date
2023-10-15
Trial ID
NCT05736562
Treatments Being Tested
To evaluate the intervention effects of Bifidobacterium animalis subsp. lac...
Status
Unknown
Location
Fakultas Kedokteran Universitas Indonesia
Start Date
2024-06-15
Trial ID
NCT06412042
Treatments Being Tested
To observe the safety/efficacy of tolvaptan for treatment of patients with ...
Status
Completed
Location
Renji hospital, Shanghai Jiaotong University School of Medicine
Start Date
2009-04
Trial ID
NCT01349335
This study tests a new nasal spray for adults (18-65 years) with chronic si...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07635459
We are doing this study to see if using an over the counter mild laxative, ...
Status
Completed
Location
Hartford Hospital
Start Date
2008-01
Trial ID
NCT00571896
Treatments Being Tested
The primary objective of the phase I trial is to evaluate the safety and to...
Status
Recruiting
Location
Zigong Center for Disease Control and Prevention
Start Date
2026-05-14
Trial ID
NCT07582796
Treatments Being Tested
Elevated aldosterone causes moderate to severe increase in blood pressure, ...
Status
Enrolling By Invitation
Location
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region
Start Date
2023-04-16
Trial ID
NCT05688579
Treatments Being Tested
Phase II:To explore the optimal effective dose of SHR7280 tablets in subjec...
Status
Unknown
Location
Peking University First Hospital
Start Date
2022-09-10
Trial ID
NCT05442827
Treatments Being Tested
Anlotinib hydrochloride is a multi-targeted receptor tyrosine kinase inhibi...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-10-31
Trial ID
NCT04073537
Treatments Being Tested
This study was a randomized, double-blind, multi-center phase III clinical ...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-05-07
Trial ID
NCT07522151
Treatments Being Tested